The present invention relates to a compound for the treatment of cancer, chronic inflammatory diseases and similar help through a new family. In terms of efficiency, they are important kinases that inhibit kinase Ab1 and converters and other forms of therapy.Compounds of protein kinase inhibitors are described in the form of general formula (I) and formula (II) compounds, or a single isomer, a_alpha___. Mixtures of isomers, medically acceptable salts, these epsilon pi_delta_alpha lambda_u alpha_or a_delta p_.
展开▼